(You can download Author Guideline in PDF, Here)
Focus and Scope
The Trends in Peptide and Protein Sciences is a peer-reviewed, print-online, scientific journal owned by Protein Technology Research Center, Shahid Beheshti University of Medical Sciences and documents in all important aspects of the research in peptides and proteins focusing on analytics and impurities, bioinformatics, biopharmaceuticals and vaccines, biotechnology, chemical synthesis, conformational analysis, design and development of protein therapeutics, determination of structure, enzymology, folding and sequencing, formulation and stability, function, genetics, immunology, kinetics, modeling, molecular biology, pharmacokinetics and pharmacodynamics of therapeutic proteins and antibodies, pharmacology, protein engineering and development, protein-protein interaction, proteomics, purification/expression/production, simulation, thermodynamics and hydrodynamics and protein biomarkers. The aim of this journal is to publish high quality original research articles, reviews, short communications and letters and to provide a medium for scientists and researchers to share their findings from the area of peptides and proteins.
Electronic Submission of Manuscript
Manuscripts must be submitted online by the Corresponding Author to the Trends in Peptide and Protein Sciences at:
First-time users are required to register at http://journals.sbmu.ac.ir/protein/user/register before submitting a manuscript. Straightforward login and registration procedures can be found on the website.
Note: you should mark "Author" as your role on "My Profile".
By submission, the author(s) confirm that the manuscript (or any parts of it) has not been published previously or is not under consideration for publication in another journal. Previous presentation in any congresses should be mentioned as a footnote in Title page and also stated in the Covering Letter. Furthermore, any illustrations, structures or tables that have been published elsewhere must be reported, and copyright permission for reproduction must be obtained.
Categories of Articles
The Trends in Peptide and Protein Sciences publishes the articles in the following categories:
All manuscripts must be accompanied by a signed cover letter in the “Comments for the Editor” and submitted by the Corresponding Author during online submission. Other than any comments, you would like to write to the editor, the following items must be addressed in this letter; importance of the work and its relevance to the journal’s scope, the name, address, telephone number, fax number, and e-mail address of the Corresponding Author. The author has to confirm in written that the manuscript (or any parts of it) has not been published previously or is not under consideration for publication in another journal. Previous presentation in any congresses should be stated in the covering letter. You are also required to mention the names of two potential preferred referees that could be considered for reviewing your manuscript.
Highlights are required for this journal. They consist of a short collection of bullet points that convey the core findings of the manuscript, including 3 to 5 bullet points (maximum 85 characters, including spaces, per bullet point), and should be submitted in a separate page following the Title page.
A colored graphic could be included with each manuscript. This must be presented in a separate page following the Abstract (preferred file types are TIFF, PNG, JPEG and Power Point, minimum 300 dpi). A graphical abstract, not exceeding 30 words along with the illustration, helps to summarize the contents of the manuscript in a concise pictorial form.
Preparation of Manuscripts
Manuscripts should be prepared according to the following mentioned stylistic. The Editors have the right to make editorial corrections and additional changes with the knowledge and approval of the Corresponding Author. The word processing format for the manuscript file must be Microsoft Word. The main manuscript should contain:
- Title Page
The title page should include:
The title of the article should be precise and brief. Authors should avoid the use of non-standard abbreviations. Use initial capital letter for each title word. The authors will be required to provide their full names and the institutional affiliations by numbers in superscripts. The Corresponding Author should be remarked with a superscripted asterisk. Authors are expected to consider carefully the list and order of authors before submitting their manuscript.
The abstract of an article should be a clear, concise and accurate summary of the work, having no more than 300 words. Use of abbreviations should be avoided and the references should not be cited in the abstract.
Author(s) should provide 4 to 6 keywords, which can be used for indexing purposes. They should be in alphabetic order and first capital letter, separated with semicolons.
- Abbreviations (if required)
The full term of each abbreviation should be written in the text before its first use. Standard and well-known abbreviations do not need explanation. All nomenclature, including gene names and symbols, should be used in a scientifically accurate manner following the nomenclature conventions adopted by the scientific community.
- Main text
When submitting a manuscript, ensure that the following sections are included separately; Introduction, Materials and Methods, Results and Discussion, Conclusion, Acknowledgements, Competing Interests and References. Introduction should be concise, without subheadings and indicates the purpose and rational of the study. Materials and Methods provide sufficient detail to allow the work to be reproduced, with details of supplier and catalogue number when appropriate. Methods already published should be indicated by a reference, only relevant modifications should be described. Discussion should explore the significance of the results of the work, not repeat them. It may contain subheadings in some sections. The detailed data should not be repeated again in Conclusion. In the case of Short Communications, Result and Discussion and Conclusion could be merged.
All contributors who do not meet the criteria for authorship should be covered in this section. Financial and material supports should also be acknowledged.
- Competing Interests
Author(s) warrant that any financial interests, direct or indirect, that exist or may be perceived to exist for individual contributors in connection with this manuscript have been disclosed in the Covering Letter and Manuscript.
- Ethical consideration
Author(s) herein confirm that all human and/or animal studies undertaken, are in compliance with the regulations of their institution(s) and generally accepted guidelines governing such work. In any studies that involve experiments on human subjects, work must be conducted in accordance with the Declaration of Helsinki. For the experiments on animal subjects, the compliance with National Institutes of Health guidelines for the human use of laboratory animals, should be declared in text.
Author(s) warrant that this manuscript contains no violation of any existing copyright or other third party right or any materials of an obscene, indecent, libelous, or otherwise unlawful nature and that to the best of their knowledge the manuscript does not infringe the rights of others.
- Author contribution
All persons who listed as authors, must certify that participated sufficiently in the work and take public responsibility for the content of appropriate portions.
Example of author contribution statement:
A.B. and B.C. conceived of the presented idea. A.B. developed the theory and performed the computations. C.D. and D.E. verified the analytical methods. B.C. encouraged A.B. to investigate [a specific aspect] and supervised the findings of this work. All authors discussed the results and contributed to the final manuscript.
- Funding Support
Financial and material support should be acknowledged, here.
All references should be listed accordance to the Harvard style. Harvard is an 'author/date' system, so your in-text citation consists of author(s) and year of publication. At the end, the authors should be listed in alphabetical order. For more guides, use the online information at http://guides.is.uwa.edu.au/harvard.
If using EndNote, cite according to Author-Date style
For Harvard in-text citation, the last name of the author(s) and the year of publication are appeared in parenthesis beside any quotation or paraphrase of a source.
Number of authors
In-text citation example
(Davis and Barrett, 2019)
(Davis et al., 2019)
When you need multiple citations to appear at the same point in your text – for example, when you refer to several sources with one phrase – you can present them in the same set of parenthesis, separated by semicolons. List them in order of publication date.
L-captopril, L-penicillamine and 2-thiopheneboronic acid inhibits…(Gillner, et al., 2009; Uda and Creus, 2011; Greenfield and Harlow, 2014; Starus, et al., 2015).
If you cite multiple sources by the same author which were published in the same year, it is important to distinguish between them in your citations. To do this, insert an ‘a’ after the year in the first one you reference, a ‘b’ in the second, and so on.
The results of the first study (Woodhouse, 2018a) were inconclusive, but a follow up study (Woodhouse, 2018b) achieved a clearer outcome.
When a source does not have a clear publication date – for example, a constantly updated reference source like Wikipedia or an obscure historical document which cannot be accurately dated – you can replace it with the words ‘no date’. For example (Scribbr, no date).
Note that when you do this with an online source, you should still include an access date in References, as in the example; Scribbr (no date) How to structure a dissertation. Available at: https://www.scribbr.co.uk/category/thesis-dissertation/ (Accessed: 14 February 2020).
When a source lacks a clearly identified author, there is often an appropriate corporate source – the organization responsible for the source – whom you can credit as author instead, as in the Google and Wikipedia examples above.
(Collins English dictionary, 2012) or (WHO, 2020), (BP, 2018).
Galar et al. (2014) identified that the risks of...SMART risk assessments...(Galar et al. 2014).
Vickers (2008) noted that the impact of technology has changed the way spaces within a library building are provided...
Learning spaces and services provided are changing due to technological advances (Vickers 2008)...
Timothy James Hollis and Fengshun Tan (2017) patented the...The helical gradient coil demonstrates...(Hollis and Tan, 2017).
Tips for citing
Bernocchi, B., Carpentier, R., Lantier, I., Ducournau, C., Dimier-Poisson, I. and D. Betbeder, (2016). ²Mechanisms allowing protein delivery in nasal mucosa using NPL nanoparticles.² Journal of Controlled Release, 232: 42–50.
Bates, R. C., Stith, B. J. and K. E. Stevens, (2015). ²Increasing pro-survival factors within whole brain tissue of Sprague Dawley rats via intracerebral administration of modified valproic acid.² Journal of Pharmacological Sciences, 128(4): 193-201.
Montgomery, D. C. (2005). ²Design and Analysis of Experiments,² 6th ed., John Wiley & Sons, Inc. New Jersey, pp. 119-159.
Silbey, R. J., Alberty, R. A. and M. G. Bawendi, (2005). ²Physical Chemistry,² 4th ed., John Wiley & Sons, Inc., New Jersey, pp. 74-101.
Chien, Y. W. (1991). ²Transdermal Route of Peptide and Protein Drug Delivery.² In: V. H. L. Lee (Ed.), Peptide and Protein Drug Delivery, Marcel Dekker, Inc., New York, pp. 667-689.
Pearlman, R. and T. H. Nguyen, (1991). ²Analysis of Protein Drugs.² In: V. H. L. Lee (Ed.), Peptide and Protein Drug Delivery, Marcel Dekker, Inc., New York, pp. 247-301.
Banerjee, P. S., Hosny, E. A. and J. R. Robinson, (1991). ²Parenteral Delivery of Peptide and Protein Drugs." In: V. H. L. Lee (Ed.), Peptide and Protein Drug Delivery, Marcel Dekker, Inc., New York, pp. 487-543.
Galar, D., Sandborn, P., Kumar, U. and C–A. Johansson, (2014). ²SMART: integrating human safety risk assessment with Asset Integrity.² In: G. Dalpiaz, R. Rubini, G. D'elia, M. Cocconcelli, F. Chaari, R. Zimroz, W. Bartelmus and M. Haddar, eds. Advances in condition monitoring of machinery in non–stationary operations, proceedings of the third international conference on condition monitoring of machinery in non–stationary operations, CMMNO, 2013, Ferrara, Italy. Berlin: Springer, pp. 37–59.
Redknap, M., (2004). ²Viking–age settlements in Wales and the evidence from Llanbedrgoch.² In: J. Hines, A. Lane and M. Redknap, eds. Land, sea and home, proceedings of a conference on Viking–period settlement, July 2001, Cardiff. Leeds: Manay Publishing, pp. 139–175.
For Online/Electronic versions add [Available from: URL or doi:]
Fujikami, S., Sumi, T., Yagiu, R. and Nagai, Y., (2015). ²Fast device discovery for vehicle–to–pedestrian communication using wireless LAN.² In: Institute of Electrical Engineers (IEEE). 12th Annual IEEE Consumer Communications and Networking Conference (CCNC 2015), 9–12 January 2015, Las Vegas, Nevada, USA [online]. New York: Institute of Electrical and Electronics Engineers. pp. 35–40. [Viewed 10 December 2015]. Available from: doi: 10.1109/CCNC.2015.7157943
Bazela, C., Grant, V. and A. Tucker, (2014). ²History of medicine 2.0: using creative media to enhance information literacy teaching for 1st year medical students [poster].² In: LILAC, 23-25 April 2014, Sheffield, United Kingdom.
For Online/Electronic versions add [Available from: URL or doi:]
Kleinschmidt, T., Fuhr, O. and Wietfeld, C., (2016). ²Synchronised charging of electric vehicles with distant renewable energy resources [Poster].² In: O. Altinas, E. Ekici, M. Tsai, M. Speulcre, B. Bloessi, and Y-L. Wei. eds. 2016 IEEE Vehicular Networking Conference (VNC), 8-10 December 2016, Columbus, OH, USA [online]. New York: Institute of Electrical and Electronics Engineers. Available from: doi: 10.1109/VNC.2016.7835983
Dalpiaz, G., Rubini, R., D'elia, G., Cocconcelli, M., Chaari, F., Zimroz, R., Bartelmus, W. and M. Haddar, eds., (2014). ²Advances in condition monitoring of machinery in non–stationary operations, proceedings of the third international conference on condition monitoring of machinery in non–stationary operations,² CMMNO, 2013, Ferrara, Italy. Berlin: Springer.
Orman, W. and M.J. Valleau, eds., (2014). ²Proceedings of the 38th annual Boston University Conference on language development,² 2013, Boston, Massachusetts. Somerville, MA; Cascadilla Press. Volume 2.
For Online/Electronic versions add [Available from: URL or doi:]
Institute of Electrical and Electronics Engineers (IEEE)., (2015). 12th Annual IEEE Consumer Communications and Networking Conference (CCNC 2015),² 9–12 January 2015, Las Vegas, Nevada, USA [Online]. New York: Institute of Electrical and Electronics Engineers. [Viewed 10 December 2015]. Available from: http://ieeexplore.ieee.org/xpl/tocresult.jsp?asf_pun=7151874
Note that the name of the conference should be used as the author if an individual author, or corporate author cannot be identified
Liu, Z. (2012). "Metabolic Engineering of Recombinant Protein Production by Saccharomyces cerevisiae." Göteborg: Chalmers University of Technology, Sweden.
Cohen, N. (2009). DNA, RNA and protein formation: Track 1. Available at: http://www.open.edu/openlearn/science-maths-technology/science/biology/dna-rna-and-protein-formation (accessed 2016-09-12).
Name of inventor (if applicable) (Year patent granted). ²Title of patent.² Applicant of patent. Date patent granted (if applicable). Date of application. Official patent series Patent Serial Number.
Hollis T. J. and F. Tan, (2017). ²Helical gradient coil for magnetic resonance imaging apparatus.² GE Medical Systems Global Technology Company LLC. 10 January. Appl: 20 August 2012. GB Patent GB2494259.
Use "World Health Organization" as the author. Place the year next. Add the title of the report next. Place the website at the end.
World Health Organization. (2020, September 22). ²Tobacco responsible for 20% of deaths from coronary heart disease.² Retrieved from https://www.who.int/news-room/detail/22-09-2020-tobacco-responsible-for-20-of-deaths-from-coronary-heart-disease
Government Agency OR Last name, First Initial., (Year published). Title of document or article. City published: Publisher, Page(s).
Pennsylvania Department of Transportation, (2012). BicyclePA Routes. Harrisburg: PENNDOT, p.1.
Organisation Responsible for the Standard. Standard number - Name of standard [Internet]. Year [revision DD Mon YYYY; cited YYYY Mon DD]. Available from: URL
Australia New Zealand Food Standards Code. Standard 1.2.5 - Date marking of packaged food [Internet]. 2012 [revised 11 Oct 2012; cited 2019 May 20]. Available from: http://www.comlaw.gov.au
Standards Australia. AS ISO 15189-2013 - Medical laboratories: requirements for quality and competence [Internet]. 2013 [cited 2019 Jan 15]. Available from: https://www.saiglobal.com
Title of work. Edition. Vol. #, volume name. Place of publication: Publisher; Year of publication. Entry title; Page/s of entry.
British Pharmacopoeia. Vol. 1. London: Medicines and Healthcare Products Regulatory Agency; 2018. Disodium hydrogen phosphate; p. 833-4.
The United States Pharmacopeia. National formulary. Vol. 1. Rockville (MD): United States Pharmacopeial Convention; 2017. Collodion; p. 1076
- Tables and Figures should be embedded at the end of the manuscript file. They must be cited in the text consecutively with Arabic numerals (Figure 1 or Table 1) and presented in separate pages. Accepted File formats for figures are TIFF, PNG and JPEG at 600 dpi or higher. Graphs and charts are considered equally to figures and accepted in the formats of TIFF, PNG and JPEG. Tables should be in Word Table format, not inserted as graphics. They should be self-explanatory, cited in the main text. Tables with their captions should be presented following the References on a separate page. A table caption should be a brief descriptive title and all other important information must be presented in the footnotes. Add Figures and Figures’ captions separately following the Tables. Equations must be presented by the equation tab of the Word. Chemical structures and reactions are presented by schemes. Equations and Schemes are also cited sequentially with Arabic numerals (Equation 1 or Scheme 1).
TPPS follows the international regulations against scientific misconduct including fabrication, falsification, plagiarism, etc. Any cases of suspected misconduct will be assessed during the peer-review and publication process based on COPE guidelines.
Plagiarism happens when someone presents works/ideas of other ones as his/her own, without full citation or acknowledgement. All submitted manuscript have to be original and there are less than 20% similarity in text with other publications, which have been checked by appropriate Plagiarism checking software.
After submission, the authorship confirmation letters will mail to all authors. They should notified the editorial office if any misconduct happened. Then, Editor-in-Chief or section Editors evaluate the submitted files before the peer-review process and the manuscript will be sent back to author(s) if do not have approval criteria or have plagiarism. In this step, authors can revise the manuscript and resubmit it. If they do not want to do the revision, the manuscript will be rejected.
If Editors discover any misconduct including fabrication, falsification, and plagiarism after publication, the manuscript will be withdrawn. Authors (at least the Corresponding author) should have close collaboration and communication with the editorial office during publication process and after if needed.
Authors’ Agreement Form
It is mandatory that a signed Authors’ Agreement Form to be sent along with the proofreading by the Corresponding Author. The Author(s) acknowledge that the publisher has the legal right to take appropriate action against the Author(s) for any violation of the terms and conditions as laid down in the Authors’ Agreement Form.
As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
There are no charges for publication in this Journal.
Upon publication, author(s) agree that the journal of Trends in Peptide and Protein Sciences is the copyright owner of the material published. All works published in the TPPS are open access and are available to anyone on the web site of the journal without cost. The users are free to use the work, subject to proper attribution of authorship and ownership of the rights. Authors may use their material in presentations and subsequent publications they write or edit themselves, provided that the TPPS is referenced in writing and is acknowledged as the original publication.
Creative Common Attribution Non-Commercial 4.0 International License (CC BY-NC 4.0)
This is an open access journals that articles distributed under the terms of Creative Common Attribution Non-Commercial 4.0 International License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work properly cited.
The names and email addresses entered in the journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purposes or to any other parties.
A preprint is considered as an author’s version of a manuscript prior to the version accepted for publication in a journal. Authors are allowed to deposit an initial draft of their manuscript anywhere. However, authors should disclose the Digital Object Identifier (DOI) once the manuscript is submitted to the journal or at any other point during the peer review process at TPPS. If the manuscript is accepted for publication, the preprint record should be updated with the DOI and a URL link to the published version of the article on the journal website. Please note that deposition of a preprint shall not be viewed as prior publication.